UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome

International journal of infectious diseases, 2020-11, Vol.100, p.327-332

2020

Volltextzugriff (PDF)

Mast cell activation symptoms are prevalent in Long-COVID

International journal of infectious diseases, 2021-11, Vol.112, p.217-226

2021

Volltextzugriff (PDF)

Rosacea and small intestinal bacterial overgrowth: Prevalence and response to rifaximin

Journal of the American Academy of Dermatology, 2013-05, Vol.68 (5), p.875-876

2013

Volltextzugriff (PDF)

Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series

Journal of personalized medicine, 2023-10, Vol.13 (11), p.1562

2023

Volltextzugriff (PDF)

Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?

Vaccines (Basel), 2022-01, Vol.10 (1), p.127

2022

Volltextzugriff (PDF)

Restless Legs Syndrome Shows Increased Silent Postmortem Cerebral Microvascular Disease With Gliosis

Journal of the American Heart Association, 2021-06, Vol.10 (11), p.e019627-e019627

2021

Volltextzugriff (PDF)

Repeat Treatment With Rifaximin is Safe and Effective in Patients With Diarrhea-predominant Irritable Bowel Syndrome

Gastroenterology (New York, N.Y. 1943), 2016-12, Vol.151 (6), p.1113-1121

2016

Volltextzugriff (PDF)

Resect and Discard Approach to Colon Polyps: Real-World Applicability Among Academic and Community Gastroenterologists

Digestive diseases and sciences, 2015-02, Vol.60 (2), p.502-508

2015

Volltextzugriff (PDF)

Colonoscopy in the tilt-down position

Gastrointestinal endoscopy, 2014-10, Vol.80 (4), p.746-746

2014

Volltextzugriff (PDF)

Restless legs syndrome – Theoretical roles of inflammatory and immune mechanisms

Sleep medicine reviews, 2012-08, Vol.16 (4), p.341-354

2012

Volltextzugriff (PDF)

Mast Cell Activation Syndrome: A Primer for the Gastroenterologist

Digestive diseases and sciences, 2021-04, Vol.66 (4), p.965-982

2021

Volltextzugriff (PDF)

Review of the role of the endogenous opioid and melanocortin systems in the restless legs syndrome

Brain (London, England : 1878), 2024-01, Vol.147 (1), p.26-38

2024

Volltextzugriff (PDF)

Efficacy and toxicity of hydroxyurea in mast cell activation syndrome patients refractory to standard medical therapy: retrospective case series

Naunyn-Schmiedeberg's archives of pharmacology, 2022-11, Vol.395 (11), p.1441-1447

2022

Volltextzugriff (PDF)

Molds, Mycotoxins, the Brain, the Gut and Misconceptions

Alternative therapies in health and medicine, 2022-03, Vol.28 (3), p.8

2022

Volltextzugriff (PDF)

Duodenal lipomatosis

Gastrointestinal endoscopy, 2013-06, Vol.77 (6), p.954-955

2013

Volltextzugriff (PDF)

The Significance of Mast Cell Activation in the Era of Precision Medicine

The American journal of gastroenterology, 2018-11, Vol.113 (11), p.1725-1726

2018

Volltextzugriff (PDF)

Restless legs syndrome is associated with long-COVID in women

Journal of clinical sleep medicine, 2022-05, Vol.18 (5), p.1413-1418

2022

Volltextzugriff (PDF)

Body positions for colonoscopy: value of Trendelenburg

Gastrointestinal endoscopy, 2009-06, Vol.69 (7), p.1409-1410

Weinstock, Leonard B., MD

2009

Volltextzugriff (PDF)

Exploring the role of the endogenous opiate system in the pathogenesis of anemia in an opiate receptor knock-out model of Restless Legs Syndrome

Medical hypotheses, 2022-10, Vol.167, p.110941, Article 110941

2022

Volltextzugriff (PDF)

Imatinib and Trigger Avoidance for Mast Cell Activation Syndrome Presenting With Attacks of Abdominal Pain, Nausea, Vomiting, and Diarrhea

ACG case reports journal, 2024-06, Vol.11 (6), p.e01383-e01383

2024

Volltextzugriff (PDF)

Naltrexone therapy for Crohn's disease and ulcerative colitis

Journal of clinical gastroenterology, 2014-09, Vol.48 (8), p.742

Weinstock, Leonard B

2014

Volltextzugriff (PDF)

Rifaximin antibiotic treatment for restless legs syndrome: a double-blind, placebo-controlled study

Sleep and biological rhythms, 2012-04, Vol.10 (2), p.145-153

2012

Volltextzugriff (PDF)

Long-Term Outcome of Rifaximin Therapy in Non-constipation Irritable Bowel Syndrome

Digestive diseases and sciences, 2011-11, Vol.56 (11), p.3389-3390

Weinstock, Leonard B.

2011

Volltextzugriff (PDF)

Restless legs syndrome is associated with mast cell activation syndrome

Journal of clinical sleep medicine, 2020-03, Vol.16 (3), p.401-408

2020

Volltextzugriff (PDF)

Occult bleeding and anemia caused by an inflammatory polyp at a sphincterotomy/stent site

Gastrointestinal endoscopy, 2011-06, Vol.73 (6), p.1286-1287

2011

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(110)

Erscheinungsjahr

n.n

Thema

Science & Technology
(83)
Life Sciences & Biomedicine
(78)
Humans
(64)
Female
(44)
Gastroenterology & Hepatology
(42)
Male
(35)
Middle Aged
(28)
Aged
(22)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Adult
(18)
Restless Legs Syndrome
(16)
Gastroenterology
(13)
Treatment Outcome
(12)
Colonoscopy
(10)
Gastroenterology. Liver. Pancreas. Abdomen
(10)
Mast Cell Activation Syndrome
(10)
Rifamycins - Therapeutic Use
(10)
Gastroenterology And Hepatology
(9)
Clinical Neurology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome

Mast cell activation symptoms are prevalent in Long-COVID

Rosacea and small intestinal bacterial overgrowth: Prevalence and response to rifaximin

Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series

Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?

Restless Legs Syndrome Shows Increased Silent Postmortem Cerebral Microvascular Disease With Gliosis

Repeat Treatment With Rifaximin is Safe and Effective in Patients With Diarrhea-predominant Irritable Bowel Syndrome

Resect and Discard Approach to Colon Polyps: Real-World Applicability Among Academic and Community Gastroenterologists

Colonoscopy in the tilt-down position

Restless legs syndrome – Theoretical roles of inflammatory and immune mechanisms

Mast Cell Activation Syndrome: A Primer for the Gastroenterologist

Review of the role of the endogenous opioid and melanocortin systems in the restless legs syndrome

Efficacy and toxicity of hydroxyurea in mast cell activation syndrome patients refractory to standard medical therapy: retrospective case series

Molds, Mycotoxins, the Brain, the Gut and Misconceptions

Duodenal lipomatosis

The Significance of Mast Cell Activation in the Era of Precision Medicine

Restless legs syndrome is associated with long-COVID in women

Body positions for colonoscopy: value of Trendelenburg

Exploring the role of the endogenous opiate system in the pathogenesis of anemia in an opiate receptor knock-out model of Restless Legs Syndrome

Imatinib and Trigger Avoidance for Mast Cell Activation Syndrome Presenting With Attacks of Abdominal Pain, Nausea, Vomiting, and Diarrhea

Naltrexone therapy for Crohn's disease and ulcerative colitis

Rifaximin antibiotic treatment for restless legs syndrome: a double-blind, placebo-controlled study

Long-Term Outcome of Rifaximin Therapy in Non-constipation Irritable Bowel Syndrome

Restless legs syndrome is associated with mast cell activation syndrome

Occult bleeding and anemia caused by an inflammatory polyp at a sphincterotomy/stent site

Suchergebnisse filtern